Australia's TGA To Publish Details Of New Drug Applications
More Transparency To Address Stakeholder ‘Frustration’
Executive Summary
A lack of information on innovative new drug filings and issues with late notification of generic and biosimilar drug applications have led the Australian authorities to introduce some new rules starting next year.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.